Clinical Trials Logo

Recurrent Peritoneal Malignant Mesothelioma clinical trials

View clinical trials related to Recurrent Peritoneal Malignant Mesothelioma.

Filter by:
  • None
  • Page 1

NCT ID: NCT02399371 Recruiting - Clinical trials for Pleural Malignant Mesothelioma

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Start date: March 2015
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well pembrolizumab works in treating patients with malignant mesothelioma, a cancer of the linings around the lungs (pleura) or abdomen (peritoneum). Monoclonal antibodies, such as pembrolizumab, work by blocking a protein called programmed cell death 1 (PD-1) which may stimulate an immune response and kill tumor cells.